Copyright © IMARC Service Pvt Ltd. All Rights Reserved Global Intravenous Solutions Market Research Report and Forecast 2024 Report Edition: 2019

Report Description About IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description Report Description and Highlights Global Intravenous Solutions Market Overview: According to the latest report by IMARC Group, titled “Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast ”, the global intravenous solutions market size reached US$ 8.0 Billion in Intravenous (IV) solutions, also known as intravenous fluids, are administered to a patient to provide salt, sugar and water directly into their venous circulation. It is required when an individual is ill, going through an operation or is not in the condition to eat or drink. IV solutions and electrolytes are mainly used for fluid resuscitation, routine maintenance, replacement, and redistribution. Nowadays, intravenous drugs, nutrition and fluids have become an integral part of modern therapy.Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast Intravenous Solution Market Trends Over the past few years, the prevalence of hectic work schedules and unhealthy lifestyles has increased across the globe. The consequent decline in physical activity and proper nutrition has led to a rise in the incidences of chronic diseases, which in turn has boosted the demand for intravenous solutions. Besides, there has been significant growth in the production of IV fluids, particularly in developed countries.

Report Description Report Description and Highlights This initiative is aimed to ensure a consistent supply of IV solutions, approved by the US FDA, across the country. On account of these factors, the market is anticipated to expand at a CAGR of 6.2% during , reaching a value of US$ 11.5 Billion in Request for a free sample report: market/requestsamplehttps:// market/requestsample

Report Description Report Description and Highlights For instance, it was reported that due to the shortage of IV saline, the US Food and Drug Administration (FDA) and other market players have been making efforts to mitigate the crisis. In line with this, the US-based marketing and technology company, Merge, partnered with the innovative medical products and services provider, B. Braun Medical, to introduce the ‘Solutions for Life’ omnichannel campaign in May Key Market Segmentation: Market Segmentation by Type Partial Parenteral Nutrition Total Parenteral Nutrition The report has bifurcated the market according to the type into partial parenteral nutrition and total parenteral nutrition. Currently, total parental nutrition is the most preferred type of IV solutions. For more information, click here: Market Segmentation by Nutrients

Report Description Report Description and Highlights Carbohydrates Salts and Electrolytes Minerals Vitamins Amino Acids Based on the nutrients, the market has been segmented as amino acids, carbohydrates, salts and electrolytes, minerals, and vitamins. Amongst these, amino acids represent the largest segment. Market Segmentation by Region North America Europe Asia Pacific Middle East and Africa Latin America On the geographical front, North America is the leading market for intravenous solutions with the majority of the total market share.

Report Description Report Description and Highlights The growth is led by the rapid expansion of production capacities in the US due to a shortage of IV fluids. Other major regions include Europe, Asia Pacific, Middle East and Africa, and Latin America. Competitive Landscape: The competitive landscape of the market has also been examined with some of the key players. Ajinomoto B. Braun Melsungen Baxter International Inc. Grifols Otsuka Pharmaceutical Browse Relate Report Healthcare IT Market Report: H1N1 Vaccines Market Report:

A partial List of our Clients We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients

A partial List of our Clients We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients

Report Description Report Description and Highlights © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

FOR MORE DETAILS Visit us at : Stay With Us: TELEPHONE: Contact Us